Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKMerryn Voysey, Angela M. Minassian, Daniel Jenkin et al.|The Lancet|2020Cited by 5k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trialsMerryn Voysey, Angela M. Minassian, Sue Ann Costa Clemens et al.|The Lancet|2021Cited by 1.2k
An Outpatient, Ambulant-Design, Controlled Human Infection Model Using Escalating Doses of Salmonella Typhi Challenge Delivered in Sodium Bicarbonate SolutionClaire S. Waddington, Andrew J. Pollard, Thomas C. Darton et al.|Clinical Infectious Diseases|2014Cited by 155
Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21aThomas C. Darton, Andrew J. Pollard, Claire Jones et al.|PLoS neglected tropical diseases|2016Cited by 83
The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveysThomas C. Darton, Andrew J. Pollard, James Meiring et al.|BMJ Open|2017Cited by 78